{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:56:43Z","timestamp":1790557003247,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004719","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T00:00:00Z","timestamp":1129680000000}}],"reference-count":86,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004719.pub2","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T07:54:39Z","timestamp":1128671679000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Estrogen for schizophrenia"],"prefix":"10.1002","volume":"2010","author":[{"given":"Wan Lian LC","family":"Chua","sequence":"first","affiliation":[{"name":"Lynfield Hospital; Craven and Airedale Drugs and Alcohol Team; 25-27 Henry Street Bradford West Yorkshire UK BD21 3DR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Izquierdo de Santiago","sequence":"additional","affiliation":[{"name":"The Mount; 44 Hyde Terrace Leeds West Yorkshire UK LS2 9LN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashri","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Monash University; Alfred Psychiatry Research Centre (APRC); 2nd floor Old Baker Building Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Mortimer","sequence":"additional","affiliation":[{"name":"University of Hull; Department of Psychiatry; Southcoates Annex Cottingham Road Hull East Yorkshire UK HU6 7RX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,19]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD004719.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0306-4530(85)90011-3","article-title":"Estrogen replacement and tardive dyskinesia","volume":"10","author":"Glazer","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0003|cit2","unstructured":"Good KP E-mail Communication with author 2004"},{"issue":"3","key":"10.1002\/14651858.CD004719.pub2-BIB0002|cit3","first-page":"131","article-title":"Hormone replacement therapy in postmenopausal women with schizophrenia: preliminary findings","volume":"12","author":"Good","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(96)82949-5","article-title":"A clinical trial of the effects of estrogen in acutely psychotic women","volume":"20","author":"Kulkarni","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0920-9964(95)95486-S","article-title":"Adjunctive estrogen treatment in women with schizophrenia","volume":"15","author":"Kulkarni","year":"1995","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0010|cit6","unstructured":"Kulkarni J E-mail Communication with author 2004"},{"issue":"1,2","key":"10.1002\/14651858.CD004719.pub2-BIB0006|cit7","first-page":"235","article-title":"Estrogen - a possible role in the treatment of schizophrenia?","volume":"49","author":"Kulkarni","year":"2001","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0007|cit8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00737-002-0001-5","article-title":"A clinical trial of adjunctive oestrogen treatment in women with schizophrenia","volume":"5","author":"Kulkarni","year":"2002","journal-title":"Archives of Women's Mental Health"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0008|cit9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0920-9964(00)00088-8","article-title":"Estrogen - a potential treatment for schizophrenia","volume":"48","author":"Kulkarni","year":"2001","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD004719.pub2-BIB0009|cit10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0920-9964(00)90362-1","article-title":"Estrogen: a potential treatment for schizophrenia?","volume":"41","author":"Kulkarni","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0012|cit11","unstructured":"Louza MR E-mail Communication with Author 2004"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0011|cit12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-9964(03)00082-3","article-title":"Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia; a double blind study","volume":"66","author":"Louza","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"12","key":"10.1002\/14651858.CD004719.pub2-BIB0013|cit13","first-page":"254","article-title":"A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia","volume":"49","author":"Marques","year":"2001","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0014|cit14","first-page":"184","article-title":"Estrogen as adjunct therapy of neuroleptic relapse prevention in schizophrenic women: a placebo-controlled, double-blind study","volume":"12","author":"Bergemann","year":"1999","journal-title":"Current Opinion in Psychiatry (Abstracts of the XI World Congress of Psychiatry, Hamburg, August 6-11, 1999)"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0015|cit15","unstructured":"Chakos M Keefe R Estrogen augmentation for women with schizophrenia Stanley Foundation Research Awards - 1999 Research Award Recipients (http:, www.stanleyresearch.org\/ accessed February 2001) 1999"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0016|cit16","unstructured":"Godfrey E Hormone replacement therapy as an adjunctive treatment for postmenopausal females with schizophrenia National Research Register 2002"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0017|cit17","unstructured":"Kim JS Kwak DI Jung IK Joe SH Estrogen augmentation in the female with chronic schizophrenia: a preliminary controlled study 21st Congress of the Collegium Internationale Neuro-psychopharmacologicum; 1998 Jul 12-16; Glasgow, Scotland 1998"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.32.5.547","article-title":"Estrogen treatment of dyskinetic disorders","volume":"32","author":"Koller","year":"1982","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004719.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0920-9964(00)90362-1","article-title":"Estrogen: a potential treatment for schizophrenia?","volume":"41","author":"Kulkarni","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD004719.pub2-BIB0020|cit20","first-page":"286","article-title":"Adjunctive estrogen in the treatment of psychotic symptoms in women: phase 2 preliminary data","volume":"12","author":"Kulkarni","year":"1999","journal-title":"Schizophrenia Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004719.pub2-BIB0021|cit21","first-page":"S184","article-title":"Clinical estrogen trials in patients with schizophrenia","volume":"12","author":"Kulkarni","year":"1999","journal-title":"Current Opinion in Psychiatry"},{"issue":"3 Suppl.1","key":"10.1002\/14651858.CD004719.pub2-BIB0022|cit22","first-page":"10","article-title":"Estrogen-a useful adjunct in the treatment of men with schizophrenia?","volume":"53","author":"Kulkarni","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004719.pub2-BIB0023|cit23","first-page":"S184","article-title":"Clinical estrogen trials in patients with schizophrenia","volume":"12","author":"Kulkarni","year":"1999","journal-title":"Current Opinion in Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004719.pub2-BIB0024|cit24","first-page":"286","article-title":"Clinical adjunctive estrogen trial in men with schizophrenia: a pilot study","volume":"12","author":"Kulkarni","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0027|cit25","unstructured":"Kulkarni J Estrogen as adjunctive treatment for women with schizophrenia Stanley Foundation Research Awards - 2000 Research Award Recipients (http:, www.stanleyresearch.org\/ accessed February 2001) 2000"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0025|cit26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0920-9964(03)80484-X","article-title":"Estrogen treatment in women with schizophrenia: Psychotic symptoms and cognitive response","volume":"60","author":"Kulkarni","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"3 Suppl.1","key":"10.1002\/14651858.CD004719.pub2-BIB0026|cit27","first-page":"10","article-title":"Estrogen-further evidence for clinical usefulness in the treatment of women with schizophrenia","volume":"53","author":"Kulkarni","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1600-0447.1983.tb09720.x","article-title":"Depo-medroxy progesterone acetate as an adjunctive treatment in three aggressive schizophrenic patients","volume":"67","author":"O'Connor","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0029|cit29","unstructured":"Purdie D Hrt and symptoms, bone mineral density and cognition in perimenopausal female patients with schizophrenia National Research Register 2000"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-0447.1951.tb09684.x","article-title":"Sex steroid therapy in psychiatric disorders","volume":"26","author":"Sackler","year":"1951","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1600-0447.2000.90067.x","article-title":"Extrapyramidal symptoms and oestrogen","volume":"101","author":"Thompson","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD004719.pub2-BIB0032|cit32","first-page":"145","article-title":"Estrogens in tardive dyskinesia in male psychiatric patients","volume":"6","author":"Villeneuve","year":"1980","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1002\/14651858.CD004719.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00421456","article-title":"Effects of conjugated estrogens on plasma butaperazine levels","volume":"39","author":"Yousef","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0034|cit34","unstructured":"Kulkarni J Three month double-blind, randomized, three arm comparison of the effects of olanzapine plus adjunctive raloxifene, estradiol 2mg plus dyhydroprogesterone or placebo in 60 post-menopausal women with schizophrenia http:\/\/www.stanleyresearch.org\/programs\/trialGrants.htm#October2003 2004"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0035|cit35","article-title":"Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]","volume-title":"The Cochrane Library","author":"Alderson","year":"2004"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia.","volume":"39","author":"Andreasen","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00380979","article-title":"Gender difference in age of onset of schizophrenia: an overview","volume":"237","author":"Angermeyer","year":"1988","journal-title":"European Archive of Psychiatry and Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD004719.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1034\/j.1600-0447.2002.01442.x","article-title":"The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia","volume":"105","author":"Baptista","year":"2002","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0040|cit40","volume-title":"Revised Visual Retention Test: Clinical and Experimental Applications","author":"Benton","year":"1963"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0041|cit41","volume-title":"Revised Visual Retention Test","author":"Benton","year":"1974"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0042|cit42","volume-title":"Multilingual Aphasia Examination","author":"Benton","year":"1983"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0044|cit44","first-page":"351","article-title":"British National Formulary","volume-title":"Royal Pharmaceutical Sociaety of Great Britian","volume":"45","author":"British Medical Association","year":"March 2003"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/S0033291700022194","article-title":"Neurodevelopmental basis of sex differences in schizophrenia","volume":"21","author":"Castle","year":"1991","journal-title":"Psychological Medicine"},{"issue":"October","key":"10.1002\/14651858.CD004719.pub2-BIB0046|cit46","first-page":"4","article-title":"Review of the evidence on long-term safety of HRT","volume":"30","author":"CSM","year":"2004","journal-title":"Current Problems in Pharmacovigilance"},{"issue":"1","key":"10.1002\/14651858.CD004719.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1139\/jpn.0202","article-title":"Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease","volume":"27","author":"Cyr","year":"2002","journal-title":"Journal of Psychiatry & Neuroscience"},{"issue":"6","key":"10.1002\/14651858.CD004719.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","article-title":"Development of the University of Pennsylvania Smell Test: standardized microencapsulated test for olfactory function","volume":"32","author":"Doty","year":"1984","journal-title":"Physiological Behaviour"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD004719.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/ajp.137.2.245","article-title":"Prevention of recurrent menstrual psychosis by an oral contraceptive","volume":"137","author":"Felthous","year":"1980","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl.1","key":"10.1002\/14651858.CD004719.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0378-5122(02)00144-5","article-title":"Hormonal influence on the central nervous system","volume":"43","author":"Genazzani","year":"2002","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD004719.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0920-9964(92)90043-5","article-title":"Gender and the familial risk for schizophrenia. Disentangling confounding factors","volume":"7","author":"Goldstein","year":"1992","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0056|cit56","volume-title":"ECDEU assessment manual for psychopharmacology, revised.","volume":"Vol. 76-338","author":"Guy","year":"1976"},{"issue":"2","key":"10.1002\/14651858.CD004719.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/070674379704200204","article-title":"Epidemiology of schizophrenia","volume":"42","author":"Hafner","year":"1997","journal-title":"Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie"},{"issue":"2","key":"10.1002\/14651858.CD004719.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0306-4530(02)00125-7","article-title":"Gender differences in schizophrenia: Prevention of recurrent menstrual psychosis by an oral contraceptive","volume":"137","author":"Hafner","year":"2003","journal-title":"Psychoneuroendocrinology: American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004719.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-1781(85)90025-3","article-title":"A Negative Symptom Rating Scale","volume":"16","author":"Iager","year":"1985","journal-title":"Psychiatry Res"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.170.3.234","article-title":"Is the earlier age at onset of schizophrenia in males a confounded finding?","volume":"170","author":"Jablensky","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0028-3932(77)90070-7","article-title":"Design Fluency: The invention of nonsense drawings after focal cortical lesions.","volume":"15","author":"Jones-Gotman","year":"1977","journal-title":"Neuropsychologia"},{"issue":"S","key":"10.1002\/14651858.CD004719.pub2-BIB0063|cit63","first-page":"41","article-title":"Localization of lesions by neuropsychological testing","volume":"32","author":"Jones-Gotman","year":"1991","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"Postitive and negative symptoms (PANNS) scale manual.","volume":"13","author":"Kay SR Kay SR.","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1192\/bjp.150.5.662","article-title":"Epidemiology of puerperal psychoses","volume":"150","author":"Kendell","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0066|cit66","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"1976"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0067|cit67","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"1995"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0068|cit68","first-page":"85","article-title":"The UKU (Udvalg for Kliniske Undersogelser) side effects rating scale","volume":"76","author":"Lingjaerd","year":"1987","journal-title":"Acta Psychiatr Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD004719.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2001.00288.x","article-title":"Oestrogen withdrawal associated psychoses","volume":"104","author":"Mahe","year":"2001","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?;176:249-52.","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0071|cit71","volume-title":"Instruction Manual for the Adult Neuropsychology Test Battery","author":"Matthews","year":"1964"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0072|cit72","first-page":"253","article-title":"Paraphrenia and paranoia","volume-title":"Schizophrenia and related syndromes","author":"McKenna","year":"1997"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.","volume":"357","author":"Moher","year":"2001","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale.","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0075|cit75","volume-title":"Manual for Administration of Neuropsychological Test Batteries for Adults and Children","author":"Reitan","year":"1969"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0076|cit76","volume-title":"L'examen clinique en psychologie","author":"Rey","year":"1958"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0920-1211(01)00214-5","article-title":"Proof of efficacy trials: cross-over versus parallel-group","volume":"45","author":"Richens","year":"2001","journal-title":"Epilepsy Research"},{"issue":"6","key":"10.1002\/14651858.CD004719.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02190244","article-title":"Schizophrenia and oestrogens - is there an association?","volume":"242","author":"Riecher-Rossler","year":"1993","journal-title":"European Archives of Psychiatry & Clinical Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD004719.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001504-200303000-00008","article-title":"Oestrogen and schizophrenia","volume":"16","author":"Riecher-Rossler","year":"2003","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD004719.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0010-440X(83)90100-1","article-title":"Interaction of sex, age, and neuroleptic dose","volume":"24","author":"Seeman","year":"1983","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/096228029900800306","article-title":"Clinical cross-over trials in phase I","volume":"8","author":"Senn","year":"1999","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side-effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD004719.pub2-BIB0084|cit84","volume-title":"The Appraisal of Children with Cerebral Deficits","author":"Taylor","year":"1959"},{"issue":"4","key":"10.1002\/14651858.CD004719.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1440-1665.2002.00504.x","article-title":"Improved functioning in a woman with schizophrenia on exclusive therapy with oestrogen pills","volume":"10","author":"Tunde-Ayinmode","year":"2002","journal-title":"Australasian Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004719.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004719.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:48:18Z","timestamp":1790556498000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004719.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2005,10,19]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004719.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,19]]}}}